Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypertension, Brain Clearance, and Markers of Neurodegeneration

NCT05785871 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT05785871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05785871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypertension, Brain Clearance, and Markers of Neurodegeneration
Lead sponsor
Weill Medical College of Cornell University
Phase
Observational
Overall status
Completed
Start date
November 18, 2020
Completion date
June 30, 2025
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, mild cognitive impairment